𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures

✍ Scribed by Lidwien Graat-Verboom; Ben EEM van den Borne; Frank WJM Smeenk; Martijn A Spruit; Emiel FM Wouters

Publisher
American Society for Bone and Mineral Research
Year
2011
Tongue
English
Weight
99 KB
Volume
26
Category
Article
ISSN
0884-0431

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

One of the extrapulmonary effects of chronic obstructive pulmonary disease (COPD) is osteoporosis. Osteoporosis is characterized by a low bone mineral density (BMD) and microarchitectural deterioration. Most studies in COPD patients use dual‐energy X‐ray absorptiometry (DXA) only to determine osteoporosis; therefore, microarchitectural changes without a low BMD are missed. The aim of this study was to determine the prevalence and correlates of osteoporosis in COPD patients based on DXA, spinal X‐rays, and combinations thereof. DXA and spinal X‐rays were obtained and pulmonary function tests, body composition, 6‐minute walking distance, medical history, and medication use were assessed in 255 clinically stable COPD outpatients of a large teaching hospital in the Netherlands. Half of all patients had radiologic evidence of osteoporosis. Combining the results of DXA with spinal X‐rays augmented the proportion of COPD patients with osteoporosis compared with both methods separately. The prevalence of osteoporosis was not significantly different after stratification for Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) stage. Most patients with osteoporosis did not receive pharmacologic treatment. Age, body mass index (BMI), and parathyroid hormone (PTH) level were significant independent correlates for osteoporosis. Chest physicians should be aware of the high prevalence of osteoporosis in patients with COPD, even in the presence of a low GOLD score, as well as especially in elder COPD patients with a low BMI and/or an increased PTH level. Β© 2011 American Society for Bone and Mineral Research.

πŸ“œ SIMILAR VOLUMES

Effect of osteoporosis on bone mineral d
Effect of osteoporosis on bone mineral density and fracture repair in a rat femoral fracture model
✍ Roseleen M. McCann; Gary Colleary; Carolyn Geddis; Susan A. Clarke; Grant R. Jor πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 263 KB πŸ‘ 2 views

## Abstract Osteoporosis (OP) is one of the most prevalent bone diseases worldwide with bone fracture the major clinical consequence. The effect of OP on fracture repair is disputed and although it might be expected for fracture repair to be delayed in osteoporotic individuals, a definitive answer

Prevalence of and risk factors for low b
Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus
✍ Irene E. M. Bultink; Willem F. Lems; Piet J. Kostense; Ben A. C. Dijkmans; Alexa πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 74 KB πŸ‘ 2 views

## Abstract ## Objective To examine the prevalence of and risk factors for low bone mineral density (BMD) and vertebral fractures in patients with systemic lupus erythematosus (SLE). ## Methods We studied 107 SLE patients. Demographic and clinical data were collected, and radiographs of the thor

Effects of bazedoxifene on bone mineral
Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal japanese women with osteoporosis
✍ Akira Itabashi; Kousei Yoh; Arkadi A Chines; Takami Miki; Masahiko Takada; Hiros πŸ“‚ Article πŸ“… 2011 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 244 KB πŸ‘ 1 views

## Abstract This randomized, double‐blind, placebo‐controlled, dose‐response late phase 2 study evaluated the efficacy and safety of bazedoxifene in postmenopausal Japanese women 85 years of age or younger with osteoporosis. Eligible subjects received daily treatment with oral doses of bazedoxifene